L.N. Rusere

University of Massachusetts Chan Medical School

MedicineImmunology and MicrobiologyChemistryMaterials Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Inhibiting HTLV-1 Protease: A Viable Antiviral Target”.

Inhibiting HTLV-1 Protease: A Viable Antiviral Target

ACS Chemical Biology(2021)10.1021/acschembio.0c00975

N/A

0.483DataRank · unranked

24 citations

M. Henes, Nathaniel Talledge, L.N. Rusere, K. Kosovrasti, E.A. Nalivaika +6 more

HIV-1 protease inhibitors with a P1 phosphonate modification maintain potency against drug-resistant variants by increased interactions with flap residues

European Journal of Medicinal Chemistry(2023)10.1016/j.ejmech.2023.115501

N/A

0.416DataRank · unranked

15 citations

L.N. Rusere, M. Henes, K. Kosovrasti, Desaboini Nageswara Rao, E. Spielvogel +7 more

Structural Analysis of Potent Hybrid HIV-1 Protease Inhibitors Containing Bis-tetrahydrofuran in a Pseudosymmetric Dipeptide Isostere

Journal of Medicinal Chemistry(2020)10.1021/acs.jmedchem.0c00529

N/A

0DataRank · unranked

7 citations

G.J. Lockbaum, M. Henes, Sook-Kyung Lee, E. Spielvogel, Desaboini Nageswara Rao +7 more

Fluorinated HIV-1 protease inhibitors containing chiral hydroxyethylbenzene and indanol as P2′ ligands with potent activity against drug-resistant variants

European Journal of Medicinal Chemistry(2025)10.1016/j.ejmech.2025.118510

N/A

0DataRank · unranked

1 citations

E. Spielvogel, Desaboini Nageswara Rao, L.N. Rusere, Ala M. Shaqra, G.J. Lockbaum +6 more